Glaucoma Clinical Trials in Miami, FL

Glaucoma Clinical Trials in Miami, FL

View the best 10 glaucoma medical studies in Miami, Florida. Access promising new therapies by applying to a Miami-based Glaucoma clinical trial.

Trials in Miami, Florida

Here are the top 10 medical studies for glaucoma in Miami, Florida

Image of Trinity Research Group in Dothan, United States.

Bimatoprost SR

Prostaglandin Analog

Recruiting2 awardsPhase 3
This trial will check the safety and effectiveness of Bimatoprost SR for people who have completed one of four other phase 3 studies on the drug.
Image of University of California San Francisco in San Francisco, United States.

Sulcus tube placement +1 More

Procedure

Recruiting1 award
This trial compares two techniques to reduce cell loss in the eye, which can help with glaucoma.
Image of OMNI Medical Services in Boca Raton, United States.

Medical Cannabis

Cannabinoid

Recruiting1 awardPhase 2
This trial will investigate if medical cannabis can effectively reduce pain and improve quality of life for patients with chronic conditions. The study will gather data through an online questionnaire about patients' use of cannabis and its effects. Medical cannabis interacts with the body's natural system to help manage pain and other symptoms. Medical cannabis has been increasingly studied and used as an alternative treatment for managing chronic pain, with numerous studies supporting its potential benefits.
Image of Kids in Distress Clinic of The Eye Care Institute in Fort Lauderdale, United States.

Cartoon video fixation target and cartoon character voice audio instructions during Humphrey perimetry

Behavioural Intervention

Recruiting1 award4 criteria
This trial aims to improve vision tests for young children by using a small screen with cartoon videos and voices. This approach helps keep children engaged, making the test results more reliable and aiding in better diagnosis and care for vision problems.
Image of Eye Research Foundation in Newport Beach, United States.

Latanoprost 0.005% +1 More

Prostaglandin Analog

Recruiting2 awardsPhase 3
This trial is testing NCX 470 eye drops to see if they can safely and effectively lower eye pressure in people with high eye pressure or glaucoma. The goal is to protect their vision by reducing the pressure inside their eyes. NCX 470 is a nitric oxide (NO)-donating bimatoprost with clinically demonstrated pressure-lowering effects.
Image of Eye Research Foundation in Newport Beach, United States.

AGN-193408 SR

Prostaglandin Analog

Recruiting1 awardPhase 1 & 2
This trial is testing a new medication called AGN-193408 SR to see if it can safely lower eye pressure in people with open-angle glaucoma or ocular hypertension.
Image of MD Stem Cells in Westport, United States.

Arm 2 +2 More

Stem Cell Therapy

Recruiting1 award8 criteria
This trial will use stem cells from patients' own bone marrow to treat severe vision loss caused by retinal or optic nerve damage. The stem cells will be injected into the eye to help repair the damaged tissues. SCOTS is the largest ophthalmology stem cell study registered at the National Institutes of Health, using autologous bone marrow-derived stem cells for retinal and optic nerve diseases.
Image of Walman Eye Center /ID# 235240 in Sun City, United States.

Bimatoprost (SR)

Prostaglandin Analog

Recruiting2 awardsPhase 3
This trial tests a long-lasting eye medication called Bimatoprost SR. It is for people with certain eye conditions who can't use regular eye drops effectively. The medication works by helping fluid drain from the eye, reducing pressure. Bimatoprost has been widely used for glaucoma management, typically delivered via eye drops, but newer methods like sustained-release implants are being explored to improve efficiency.
Image of Ocular Therapeutiux, Inc. in Delray Beach, United States.

OTX-TIC low dose Travoprost Intracameral Implant +2 More

Prostaglandin Analog

Recruiting3 awardsPhase 2
This trial tests a small device that releases medication inside the eye to help patients with high eye pressure due to glaucoma or ocular hypertension. The medication helps fluid drain from the eye, reducing pressure and preventing vision problems.
Image of Global Research Management, Inc. in Glendale, United States.

T4090 +1 More

Procedure

Recruiting1 awardPhase 2
This trial aims to compare the effectiveness and safety of two different concentrations of T4090 eye drops (0.2% and 0.3%) with Rhopressa® eye drops in reducing

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.